Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation

Transplantation

Volumn 70, Issue 4, 2000, Pages 674-680

  Pelletier, Ronald ^a,c   Pravica, Vera ^b   Perrey, Chris ^b   Xia, Dongyuan ^a   Ferguson, Ronald M ^a   Hutchinson, Ian ^b   Orosz, Charles ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GAMMA INTERFERON; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GRAFT FAILURE; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034721330     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008270-00023     Document Type: Article

References (58)

1. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha
2. Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages
3. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells
4. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro
5. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons
6. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages
7. Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells
8. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines
9. Immune interferon activates multiple class II major histocompatibility complex genes land the associated invariant chain gene in human endothelial cells and dermal fibroblasts
10. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells
11. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
12. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection
13. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
14. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression
15. IL-10 inhibits cytokine production by activated macrophages
16. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
17. Further studies of the role of transforming growth factor-beta in human B cell function
18. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes
19. A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus
20. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation
21. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression
22. Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells
23. T helper type i development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta
24. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells
25. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta
26. Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators
27. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts
28. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta
29. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
30. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
31. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha
32. An investigation of polymorphism in the interleukin-10 gene promoter
33. In vitro production of IFN-g correlates with CA repeat polymorphism in the human IFN-g gene
34. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
35. Cytokine gene polymorphism and heart transplant rejection
36. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
37. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation
38. An investigation of polymorphism in the interleukin-10 gene promoter
39. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection
40. Renal allograft rejection: The temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1
41. Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients
42. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy
43. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression
44. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies
45. Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients
46. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients
47. Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection
48. Intragraft expression of IL-10 messenger R.N.A.: A novel correlate of renal allograft rejection
49. Clinical application of molecular biology: A study of allograft rejection with polymerase chain reaction
50. Interleukin-12 mRNA levels in renal allograft fine-needle aspirates do not correlate with acute transplant rejection
51. Gamma-interferon gene expression in human renal allograft fine-needle aspirates
52. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection
53. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
54. Transforming growth factor-b levels in human allograft chronic fibrosis correlate with rate of decline in renal function
55. Intragraft TGF-beta 1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy
56. Transforming growth factor-b and matrix protein expression in acute and chronic rejection of human renal allografts
57. Expression of cytokine genes in human cardiac allografts: Correlation of IL-6 and transforming growth factor-beta (TGF-beta) with histological rejection
58. A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-G gene polymorphisms in normal individuals